e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
New treatments for asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Statins and outcome of COPD patients after hospitalization for COPD exacerbations
K. Bartziokas, A. Papaioannou, M. Minas, A. Haniotou, K. Gourgoulianis, K. Kostikas (Larissa, Athens, Greece)
Source:
Annual Congress 2010 - New treatments for asthma and COPD
Session:
New treatments for asthma and COPD
Session type:
Thematic Poster Session
Number:
1162
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Bartziokas, A. Papaioannou, M. Minas, A. Haniotou, K. Gourgoulianis, K. Kostikas (Larissa, Athens, Greece). Statins and outcome of COPD patients after hospitalization for COPD exacerbations. Eur Respir J 2010; 36: Suppl. 54, 1162
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Cardiovascular medications and mortality in patients hospitalised with acute exacerbations of COPD
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
Rehospitalizations for an acute exacerbation among patients with COPD
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Predictors of exacerbations of COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 284s
Year: 2005
Characterization of readmissions in patients hospitalized with COPD exacerbation
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
COPD mortality after severe exacerbations
Source: Virtual Congress 2020 – Monitoring of patients with COPD
Year: 2020
The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Predictors of exacerbations requiring hospitalisation in patients with stable COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 177s
Year: 2006
Predictors of readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013
Predictors of mortality in COPD patients after hospitalization due to an exacerbation
Source: International Congress 2019 – Exacerbations of airway diseases
Year: 2019
Risk factors for another hospitalization in COPD patients hospitalized for exacerbation
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
The impact of bronchiectasis on outcomes in a large cohort of patients hospitalised with exacerbations of COPD
Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients
Year: 2013
Key factors associated with readmission in COPD patients
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Efficacy of roflumilast with concomitant cardiovascular medication in patients with COPD
Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management
Year: 2013
Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015
Prognosis after hospitalization for acute exacerbations of COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 209s
Year: 2001
Early re-admissions after severe COPD exacerbations
Source: Eur Respir J 2003; 22: Suppl. 45, 511s
Year: 2003
The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
COPD patients admitted in ICU for acute exacerbation: Impact of exacerbation factors on prognosis
Source: International Congress 2016 – Dealing with the complexity of critically-ill patients
Year: 2016
COPD patients with asthma, characteristics and risk of exacerbations
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept